Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Organic Chemistry · India · 2023-09-17

Processing Time
6 days
Decision Date
2023-09-17
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his work in organic chemistry, specifically focusing on the design and synthesis of disease-specific small-molecule drugs. His research aims to develop better, cheaper, and more effective methods and materials for treating glioblastoma and other neurological disorders. This work is intended to alleviate the rising burden of nervous system cancers on the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the 10th leading cause of death in the U.S. by developing drugs for neurological disorders and cancer.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., 20 publications, and 679 citations demonstrate a track record of success and influence in the field.

3 Waiver of Job Offer and Labor Certification Met

The potential for cheaper and more effective cancer treatments makes it beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in chemistry and a record of 20 peer-reviewed journal articles and 1 preprint. His work garnered 679 citations, with 12 papers identified as highly cited in his field, and he completed 33 peer reviews. The case satisfied all three Dhanasar prongs, supported by 2 expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Scientist

Research and Development · Hong Kong

WeGreened EB-2 (NIW) approved
Massachusetts 80 days 2022-04-23
The petitioner proposes to continue research on developing and improving oncology and neurology drugs and treatment methods. The work focuses on validating new therapeutic targets and developing molecular treatments for prominent diseases, including cancer, to improve global public health outcomes.
View Case

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
California 174 days 2022-09-29
The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.
View Case

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.
View Case

Research Scientist

Research and Development · Vietnam

WeGreened EB-2 (NIW) approved
Massachusetts 820 days 2022-04-13
The petitioner proposes to continue his research on designing, synthesizing, and analyzing the structures of organic compounds, including natural products and synthetic organic compounds. This work aims to discover new therapeutic drugs and improve the processes used to design and produce pharmaceuticals.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-09-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist